Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Aerin Medical
This is a non-significant risk, prospective, multi-center, non-randomized study to evaluate the safety and efficacy of the Aerin Medical device (Vivaer Stylus) when used to deliver radiofrequency (RF) energy to the nasal valve area to improve symptoms in those diagnosed with nasal airway obstruction.
Age
22–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Seeking treatment for nasal obstruction and willing to undergo an office-based procedure
Nasal Obstruction Symptom Evaluation (NOSE) score of ≥ 60 at Baseline
Nasal valve is a primary or significant contributor to the subject's nasal obstruction as determined by the study investigator (based on clinical presentation, physical examination, nasal endoscopy, etc.) and the subject has a positive response to any of the following temporary measures (based on patient history or office exam):
Use of external nasal dilator strips (e.g., Breathe Right Strips)
Q-Tip test (manual intranasal lateralization)
Use of nasal stents
Cottle Maneuver (manual lateral retraction of the cheek)
You may not be if
Prior surgical treatment of the nasal valve
Rhinoplasty, septoplasty, inferior turbinate reduction or other surgical nasal procedures within the past twelve (12) months
Chronic sinusitis, recurrent sinusitis, or allergies leading to nasal obstruction
Septal deviation, turbinate hypertrophy, polyps, or ptotic nose tip believed to be a significant contributor to the subject's nasal obstruction symptoms
Known or suspected allergies or contraindications for any general or local anesthetic agents and / or any antibiotic medications
Known or suspected to be pregnant, or is lactating
Other medical conditions which in the opinion of the investigator could predispose the subject to poor wound healing or increased surgical risk
Clareo Health | Treatment of Nasal Airway Obstruction Using the Aerin Medical Device
